Listed

Akebia Therapeutics, Inc.

AKBANasdaqCIK 1517022HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$49.1m, Q2 FY2026
Operating income−$6.3m, Q2 FY2026
Net income−$8.9m, Q2 FY2026
Akebia Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m42.0Revenue, Q3 FY2023, three months to 2023-09-30$42.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure56.2Revenue, Q4 FY2023, three months to 2023-12-31$56.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure32.6Revenue, Q1 FY2024, three months to 2024-03-31$32.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure43.6Revenue, Q2 FY2024, three months to 2024-06-30$43.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001628280-25-038600.Report this figure37.4Revenue, Q3 FY2024, three months to 2024-09-30$37.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure46.5Revenue, Q4 FY2024, three months to 2024-12-31$46.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure57.3Revenue, Q1 FY2025, three months to 2025-03-31$57.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure62.5Revenue, Q2 FY2025, three months to 2025-06-30$62.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure58.8Revenue, Q3 FY2025, three months to 2025-09-30$58.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure57.6Revenue, Q4 FY2025, three months to 2025-12-31$57.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure53.5Revenue, Q1 FY2026, three months to 2026-03-31$53.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure49.1Revenue, Q2 FY2026, three months to 2026-06-30$49.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Cost of revenue$m18.0Cost of revenue, Q3 FY2023, three months to 2023-09-30$18.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure18.7Cost of revenue, Q4 FY2023, three months to 2023-12-31$18.7m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure11.6Cost of revenue, Q1 FY2024, three months to 2024-03-31$11.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure17.0Cost of revenue, Q2 FY2024, three months to 2024-06-30$17.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-07, accession 0001628280-25-038600.Report this figure14.2Cost of revenue, Q3 FY2024, three months to 2024-09-30$14.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure20.4Cost of revenue, Q4 FY2024, three months to 2024-12-31$20.4m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure7.6Cost of revenue, Q1 FY2025, three months to 2025-03-31$7.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure9.9Cost of revenue, Q2 FY2025, three months to 2025-06-30$9.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure9.4Cost of revenue, Q3 FY2025, three months to 2025-09-30$9.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure12.5Cost of revenue, Q4 FY2025, three months to 2025-12-31$12.5m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure12.3Cost of revenue, Q1 FY2026, three months to 2026-03-31$12.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure10.4Cost of revenue, Q2 FY2026, three months to 2026-06-30$10.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Research and development$m13.3Research and development, Q3 FY2023, three months to 2023-09-30$13.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure9.9Research and development, Q4 FY2023, three months to 2023-12-31$9.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure9.7Research and development, Q1 FY2024, three months to 2024-03-31$9.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure7.6Research and development, Q2 FY2024, three months to 2024-06-30$7.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001628280-25-038600.Report this figure8.5Research and development, Q3 FY2024, three months to 2024-09-30$8.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure11.8Research and development, Q4 FY2024, three months to 2024-12-31$11.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure9.8Research and development, Q1 FY2025, three months to 2025-03-31$9.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure11.0Research and development, Q2 FY2025, three months to 2025-06-30$11.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure14.9Research and development, Q3 FY2025, three months to 2025-09-30$14.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure26.6Research and development, Q4 FY2025, three months to 2025-12-31$26.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure14.8Research and development, Q1 FY2026, three months to 2026-03-31$14.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure14.1Research and development, Q2 FY2026, three months to 2026-06-30$14.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Selling, general and administrative$m22.7Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$22.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure25.4Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$25.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure25.4Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$25.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure26.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$26.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0001628280-25-038600.Report this figure26.5Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$26.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure27.7Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$27.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure25.7Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$25.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure26.6Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$26.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure29.1Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$29.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure26.1Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$26.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure30.4Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$30.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure28.2Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$28.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Operating income$m(13.0)Operating income, Q3 FY2023, three months to 2023-09-30−$13.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure1.4Operating income, Q4 FY2023, three months to 2023-12-31$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure(14.9)Operating income, Q1 FY2024, three months to 2024-03-31−$14.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure(8.7)Operating income, Q2 FY2024, three months to 2024-06-30−$8.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001628280-25-038600.Report this figure(12.5)Operating income, Q3 FY2024, three months to 2024-09-30−$12.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure(14.3)Operating income, Q4 FY2024, three months to 2024-12-31−$14.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure13.5Operating income, Q1 FY2025, three months to 2025-03-31$13.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure14.1Operating income, Q2 FY2025, three months to 2025-06-30$14.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure4.4Operating income, Q3 FY2025, three months to 2025-09-30$4.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure(8.6)Operating income, Q4 FY2025, three months to 2025-12-31−$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure(4.7)Operating income, Q1 FY2026, three months to 2026-03-31−$4.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure(6.3)Operating income, Q2 FY2026, three months to 2026-06-30−$6.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Income tax$mnot reportednot reportednot reportednot reported0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure0.6Income tax, Q3 FY2025, three months to 2025-09-30$615.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure1.0Income tax, Q4 FY2025, three months to 2025-12-31$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2026, three months to 2026-03-31$126.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$70.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Net income$m(14.5)Net income, Q3 FY2023, three months to 2023-09-30−$14.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure0.6Net income, Q4 FY2023, three months to 2023-12-31$614.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure(18.0)Net income, Q1 FY2024, three months to 2024-03-31−$18.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure(8.6)Net income, Q2 FY2024, three months to 2024-06-30−$8.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure(20.0)Net income, Q3 FY2024, three months to 2024-09-30−$20.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure(22.8)Net income, Q4 FY2024, three months to 2024-12-31−$22.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure6.1Net income, Q1 FY2025, three months to 2025-03-31$6.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure0.2Net income, Q2 FY2025, three months to 2025-06-30$247.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure0.5Net income, Q3 FY2025, three months to 2025-09-30$540.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure(12.2)Net income, Q4 FY2025, three months to 2025-12-31−$12.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure(9.1)Net income, Q1 FY2026, three months to 2026-03-31−$9.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure(8.9)Net income, Q2 FY2026, three months to 2026-06-30−$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Diluted EPS$ per share(0.08)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figurenot reported(0.09)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure(0.04)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001628280-25-038600.Report this figure(0.10)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figurenot reported0.03Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure0.00Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure0.00Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figurenot reported(0.03)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure(0.03)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Basic EPS$ per share(0.08)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figurenot reported(0.09)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure(0.04)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001628280-25-038600.Report this figure(0.10)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figurenot reported0.03Basic EPS, Q1 FY2025, three months to 2025-03-31$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure0.00Basic EPS, Q2 FY2025, three months to 2025-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure0.00Basic EPS, Q3 FY2025, three months to 2025-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figurenot reported(0.03)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure(0.03)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure

Balance sheet

Cash and equivalents$155.5m, Q2 FY2026
Long-term debt$24.8m, Q2 FY2026
Shareholders' equity$25.0m, Q2 FY2026
Akebia Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m46.5Cash and equivalents, Q3 FY2023, at 2023-09-30$46.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0001628280-23-037557.Report this figure42.9Cash and equivalents, FY2023, at 2023-12-31$42.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001517022-26-000020.Report this figure42.0Cash and equivalents, Q1 FY2024, at 2024-03-31$42.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001628280-24-021945.Report this figure39.5Cash and equivalents, Q2 FY2024, at 2024-06-30$39.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001628280-24-035879.Report this figure34.0Cash and equivalents, Q3 FY2024, at 2024-09-30$34.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure51.9Cash and equivalents, FY2024, at 2024-12-31$51.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001517022-26-000020.Report this figure113Cash and equivalents, Q1 FY2025, at 2025-03-31$113.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure137Cash and equivalents, Q2 FY2025, at 2025-06-30$137.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001628280-25-038600.Report this figure166Cash and equivalents, Q3 FY2025, at 2025-09-30$166.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure185Cash and equivalents, FY2025, at 2025-12-31$184.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure163Cash and equivalents, Q1 FY2026, at 2026-03-31$162.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure156Cash and equivalents, Q2 FY2026, at 2026-06-30$155.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Current assets$m110Current assets, Q3 FY2023, at 2023-09-30$109.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001628280-23-037557.Report this figure118Current assets, FY2023, at 2023-12-31$118.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-13, accession 0001628280-25-012470.Report this figure113Current assets, Q1 FY2024, at 2024-03-31$112.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001628280-24-021945.Report this figure112Current assets, Q2 FY2024, at 2024-06-30$112.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001628280-24-035879.Report this figure100Current assets, Q3 FY2024, at 2024-09-30$100.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure114Current assets, FY2024, at 2024-12-31$113.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001517022-26-000020.Report this figure204Current assets, Q1 FY2025, at 2025-03-31$203.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure235Current assets, Q2 FY2025, at 2025-06-30$234.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001628280-25-038600.Report this figure258Current assets, Q3 FY2025, at 2025-09-30$258.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure253Current assets, FY2025, at 2025-12-31$253.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure243Current assets, Q1 FY2026, at 2026-03-31$243.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure230Current assets, Q2 FY2026, at 2026-06-30$229.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Total assets$m235Total assets, Q3 FY2023, at 2023-09-30$235.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001628280-23-037557.Report this figure242Total assets, FY2023, at 2023-12-31$241.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-13, accession 0001628280-25-012470.Report this figure225Total assets, Q1 FY2024, at 2024-03-31$225.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001628280-24-021945.Report this figure220Total assets, Q2 FY2024, at 2024-06-30$220.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001628280-24-035879.Report this figure207Total assets, Q3 FY2024, at 2024-09-30$207.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure221Total assets, FY2024, at 2024-12-31$220.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001517022-26-000020.Report this figure310Total assets, Q1 FY2025, at 2025-03-31$310.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure346Total assets, Q2 FY2025, at 2025-06-30$345.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001628280-25-038600.Report this figure364Total assets, Q3 FY2025, at 2025-09-30$364.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure377Total assets, FY2025, at 2025-12-31$376.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure363Total assets, Q1 FY2026, at 2026-03-31$362.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure350Total assets, Q2 FY2026, at 2026-06-30$349.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Current liabilities$m79.7Current liabilities, Q3 FY2023, at 2023-09-30$79.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001628280-23-037557.Report this figure99.9Current liabilities, FY2023, at 2023-12-31$99.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-13, accession 0001628280-25-012470.Report this figure66.5Current liabilities, Q1 FY2024, at 2024-03-31$66.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001628280-24-021945.Report this figure107Current liabilities, Q2 FY2024, at 2024-06-30$107.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001628280-24-035879.Report this figure65.7Current liabilities, Q3 FY2024, at 2024-09-30$65.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure80.9Current liabilities, FY2024, at 2024-12-31$80.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001517022-26-000020.Report this figure91.2Current liabilities, Q1 FY2025, at 2025-03-31$91.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure119Current liabilities, Q2 FY2025, at 2025-06-30$118.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001628280-25-038600.Report this figure133Current liabilities, Q3 FY2025, at 2025-09-30$133.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure163Current liabilities, FY2025, at 2025-12-31$162.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure174Current liabilities, Q1 FY2026, at 2026-03-31$173.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure161Current liabilities, Q2 FY2026, at 2026-06-30$160.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Total liabilities$m274Total liabilities, Q3 FY2023, at 2023-09-30$274.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001628280-23-037557.Report this figure272Total liabilities, FY2023, at 2023-12-31$272.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-13, accession 0001628280-25-012470.Report this figure253Total liabilities, Q1 FY2024, at 2024-03-31$252.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001628280-24-021945.Report this figure254Total liabilities, Q2 FY2024, at 2024-06-30$253.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001628280-24-035879.Report this figure258Total liabilities, Q3 FY2024, at 2024-09-30$257.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure270Total liabilities, FY2024, at 2024-12-31$269.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001517022-26-000020.Report this figure286Total liabilities, Q1 FY2025, at 2025-03-31$285.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure316Total liabilities, Q2 FY2025, at 2025-06-30$316.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001628280-25-038600.Report this figure323Total liabilities, Q3 FY2025, at 2025-09-30$322.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure344Total liabilities, FY2025, at 2025-12-31$344.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure335Total liabilities, Q1 FY2026, at 2026-03-31$335.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure325Total liabilities, Q2 FY2026, at 2026-06-30$324.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Long-term debt$m34.6Long-term debt, Q3 FY2023, at 2023-09-30$34.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-08, accession 0001628280-23-037557.Report this figure17.2Long-term debt, FY2023, at 2023-12-31$17.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-13, accession 0001628280-25-012470.Report this figure30.1Long-term debt, Q1 FY2024, at 2024-03-31$30.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-09, accession 0001628280-24-021945.Report this figure38.0Long-term debt, Q2 FY2024, at 2024-06-30$38.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-08, accession 0001628280-24-035879.Report this figure38.4Long-term debt, Q3 FY2024, at 2024-09-30$38.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure38.7Long-term debt, FY2024, at 2024-12-31$38.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-26, accession 0001517022-26-000020.Report this figure46.5Long-term debt, Q1 FY2025, at 2025-03-31$46.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure47.1Long-term debt, Q2 FY2025, at 2025-06-30$47.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-07, accession 0001628280-25-038600.Report this figure47.6Long-term debt, Q3 FY2025, at 2025-09-30$47.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure48.3Long-term debt, FY2025, at 2025-12-31$48.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure36.4Long-term debt, Q1 FY2026, at 2026-03-31$36.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure24.8Long-term debt, Q2 FY2026, at 2026-06-30$24.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Current portion of debt$m8.0Current portion of debt, Q3 FY2023, at 2023-09-30$8.0m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-08, accession 0001628280-23-037557.Report this figure17.5Current portion of debt, FY2023, at 2023-12-31$17.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-13, accession 0001628280-25-012470.Report this figure0.0Current portion of debt, Q1 FY2024, at 2024-03-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-09, accession 0001628280-24-021945.Report this figure0.0Current portion of debt, Q2 FY2024, at 2024-06-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-08, accession 0001628280-24-035879.Report this figure0.0Current portion of debt, Q3 FY2024, at 2024-09-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-13, accession 0001628280-25-012470.Report this figurenot reportednot reportednot reported0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure12.5Current portion of debt, Q1 FY2026, at 2026-03-31$12.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure24.8Current portion of debt, Q2 FY2026, at 2026-06-30$24.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure
Shareholders' equity$m(39.4)Shareholders' equity, Q3 FY2023, at 2023-09-30−$39.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure(30.6)Shareholders' equity, FY2023, at 2023-12-31−$30.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001517022-26-000020.Report this figure(27.3)Shareholders' equity, Q1 FY2024, at 2024-03-31−$27.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure(33.8)Shareholders' equity, Q2 FY2024, at 2024-06-30−$33.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure(50.4)Shareholders' equity, Q3 FY2024, at 2024-09-30−$50.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure(49.2)Shareholders' equity, FY2024, at 2024-12-31−$49.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure24.6Shareholders' equity, Q1 FY2025, at 2025-03-31$24.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure29.2Shareholders' equity, Q2 FY2025, at 2025-06-30$29.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure41.6Shareholders' equity, Q3 FY2025, at 2025-09-30$41.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure32.6Shareholders' equity, FY2025, at 2025-12-31$32.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure27.4Shareholders' equity, Q1 FY2026, at 2026-03-31$27.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure25.0Shareholders' equity, Q2 FY2026, at 2026-06-30$25.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure

Cash flow

Operating cash flow$3.5m, Q2 FY2026
Capital expenditure$1.1m, Q2 FY2026
Akebia Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(7.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001628280-24-045979. Derived: 9-month figure less the 6-month figure.Report this figure(2.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure(19.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$19.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure(10.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$10.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001628280-25-038600. Derived: 6-month figure less the 3-month figure.Report this figure(6.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001517022-25-000046. Derived: 9-month figure less the 6-month figure.Report this figure(4.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure(13.6)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$13.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure22.3Operating cash flow, Q2 FY2025, three months to 2025-06-30$22.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001517022-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure28.1Operating cash flow, Q3 FY2025, three months to 2025-09-30$28.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001517022-25-000046. Derived: 9-month figure less the 6-month figure.Report this figure31.1Operating cash flow, Q4 FY2025, three months to 2025-12-31$31.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure(21.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$21.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure3.5Operating cash flow, Q2 FY2026, three months to 2026-06-30$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001517022-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001628280-24-045979. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$29.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001628280-25-038600. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001517022-25-000046. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$18.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$126.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001517022-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$77.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001517022-25-000046. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$70.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001517022-26-000020. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$62.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure1.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001517022-26-000051. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)269.60m, Q2 FY2026
Akebia Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares184Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30183,882,446 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001628280-23-037557.Report this figure185Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31184,768,983 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001628280-24-021945.Report this figure187Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30186,817,431 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001628280-24-035879.Report this figure188Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30188,306,350 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001628280-24-045979.Report this figure205Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31204,955,151 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001628280-25-023460.Report this figure210Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30209,705,397 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001628280-25-038600.Report this figure210Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30210,348,459 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure242Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31241,602,853 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure271Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30271,104,020 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure274Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30274,372,722 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001517022-25-000046.Report this figure267Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31267,046,755 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001517022-26-000039.Report this figure270Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30269,602,747 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure

Shares outstanding: 277.11mShares outstanding, period not labelled, at 2026-07-31277,106,245 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001517022-26-000051.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.